May Health Completes Treatment of Five Participants in U.S. Feasibility Study of its Ovarian Rebalancing Treatment for PCOS-related Infertility May Health, a clinical-stage medical device company dedicated to helping those living with the endocrine disorder polycystic ovary syndrome (PCOS), announced that it has completed treatment of the first five participants enrolled in a U.S. feasibility study of its investigational Ovarian Rebalancing™ treatment,…
